Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Insmed Inc. buy Barclays PLC

Start price
€43.00
29.05.24 / 50%
Target price
€58.07
29.05.25
Performance (%)
43.02%
End price
€61.50
30.05.25
Summary
This prediction ended on 30.05.25 with a price of €61.50. The BUY prediction by Barclays_PLC for Insmed Inc. saw massive gains of 43.02%. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Insmed Inc. -6.250% -6.250% 137.410%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by Barclays_PLC for this prediction

In the thread Insmed Inc. diskutieren
Prediction Buy
Perf. (%) 43.02%
Target price 58.067
Change
Ends at 29.05.25

Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $40.00 to $63.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat

In the thread Trading Insmed Inc.
Prediction Buy
Perf. (%) 43.02%
Target price 58.067
Change
Ends at 29.05.25

Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Barclays_PLC for Insmed Inc.

buy
Insmed Inc.

Start price
Target price
Perf. (%)
€26.80
11.04.24
€37.34
11.04.25
123.88%
12.04.25